Nexium Control (Esomeprazole)

Esomeprazole, the active ingredient in Nexium Control, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid production and is indicated for conditions such as gastro‑oesophageal reflux disease and related acid‑related disorders.

GNH USA supplies Nexium Control as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole acts on the gastric acid secretion pathway and is employed for several acid‑related conditions.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive esophagitis: accelerates mucosal healing and reduces further erosion. - NSAID‑induced gastric ulcer: protects the gastric mucosa and facilitates ulcer resolution. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours.

Adverse reactions may occur with esomeprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: usually self‑limiting. - Nausea: occasional, may improve with food. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Severe allergic reactions: anaphylaxis or angioedema. - Stevens‑Johnson syndrome/toxic epidermal necrolysis: rare skin manifestations. - Hepatic enzyme elevation: monitor liver function. - Hypomagnesemia: prolonged use may lower magnesium levels. - Acute pancreatitis: rare but serious pancreatic inflammation.

Before initiating therapy, consider the following precautions.

- Assess renal function: adjust use in severe renal impairment. - Monitor magnesium levels: prolonged treatment may cause hypomagnesemia. - Review concomitant antiretrovirals: potential reduction in antiviral efficacy. - Use cautiously in hepatic impairment: dose may need adjustment. - Store at room temperature: keep in the original pack, protect from moisture.

Esomeprazole may interact with several medicines.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption of atazanavir. - High‑dose methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: potential rise in serum digoxin levels. - Diazepam: may elevate diazepam concentrations.